E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/31/2006 in the Prospect News Bank Loan Daily and Prospect News Biotech Daily.

S&P assigns Orthofix Holdings loan BB-

Standard & Poor's said in a corrected rating that it assigned its secured loan and recovery ratings to Orthofix Holdings Inc.'s proposed $45 million revolving credit facility maturing in 2012 and $330 million term loan B maturing in 2013.

The loan was rated BB-, at the same level as the corporate credit rating on parent company Orthofix International NV, with a recovery rating of 2, S&P noted.

The agency said the BB- corporate credit rating on Orthofix International was affirmed and actually removed from CreditWatch, where its was placed with negative implications Aug. 7, due to concerns about the company's post-acquisition debt leverage, S&P said.

The outlook is stable.

S&P said that the BB- rating is based on Orthofix's operation in highly competitive markets, potential integration difficulties, significant debt leverage and the recent shortfall of operating cash flow in 2006.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.